Sigrid Strand Skånland

Sigrid S. Skånland received her PhD from the Faculty of Mathematics and Natural Sciences at University of Oslo in 2009, under the supervision of Prof. Kirsten Sandvig. She was then awarded with a long-term EMBO fellowship to do her post-doctoral training in the Molecular Signaling Group of Prof. Ivan Dikic (2009-2011) at the University Hospital Frankfurt, Germany. From 2011, Skånland has been affiliated with the group of Prof. Kjetil Taskén where she has established her own project group focusing on functional precision medicine in hematologic cancers, in particular the B-cell malignancy chronic lymphocytic leukemia. By performing functional analyses including ex vivo drug sensitivity screening and single cell signaling analyses on patient cells, her aim is to identify biomarker signatures that can predict treatment outcomes for the individual patient. Skånland has coordinated the European Commission ERA PerMed consortium CLL-CLUE (6 partners in Europe) on tailoring the targeted treatment of chronic lymphocytic leukemia, and is now coordinator of the follow-up EP PerMed consortium CLL-OUTCOME (7 partners). In 2023, she was awarded “Researcher of the year” at the Institute for Cancer Research, and in 2025 she received the Dr. Ragnar Mørk’s Prize for Excellent Cancer Research.